当前位置: 首页 > 详情页

Wilms’ tumor 1 (Wt1): The vaccine for cancer(Open Access)

文献详情

资源类型:
Pubmed体系:
机构: [1]Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA [2]Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA [3]Department of Thoracic Surgery, Xuanwu Hospital Capital Medical University, Beijing, China
出处:
ISSN:

关键词: Cancer medicine Cancer vaccine Clinical trials Immunotherapy Leukemia Peptide-based vaccine Preclinical trails Solid cancer Toxicity WT1 gene

摘要:
Vaccines have been used to fight and protect against infectious diseases for centuries. With the emergence of immunotherapy in cancer treatment, researchers began investigating vaccines that could be used against cancer, especially against tumors that are resistant to conservative chemotherapy, surgery, and radiotherapy. The Wilms’ tumor 1 (WT1) protein is immunogenic, has been detected in almost all types of malignancies, and has played a significant role in prognosis and disease monitoring. In this article, we review recent developments in the treatment of various types of cancers with the WT1 cancer vaccine; we also discuss theoretic considerations of various therapeutic approaches, which were based on preclinical and clinical data. © Innovative Healthcare Institute.

语种:
PubmedID:
第一作者:
第一作者机构: [1]Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16409 今日访问量:0 总访问量:869 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院